CoChat

The therapeutic potential of GLP‐1 receptor biased agonism

Open access
Jones, Ben · 2022 · British Journal of Pharmacology
Cited by 98

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are effective treatments for type 2 diabetes as they stimulate insulin release and promote weight loss through appetite suppression. Their main side effect is nausea. All approved GLP‐1 agonists are full agonists across multiple signalling pathways. However, selective engagement with specific intracellular effectors, or biased agonism, has been touted as a means to improve GLP‐1 agonists therapeutic efficacy. In this review, I critically examine how GLP‐1 receptor‐mediated intracellular signalling is linked to physiological responses and discuss the implications of recent studies investigating the metabolic effects of biased GLP‐1 agonists. Overall, there is little conclusive evidence that beneficial and adverse effects of GLP‐1 agonists are attributable to distinct, nonoverlapping signalling pathways. Instead, G protein‐biased GLP‐1 agonists appear to achieve enhanced anti‐hyperglycaemic efficacy by avoiding GLP‐1 receptor desensitisation and downregulation, partly via reduced β‐arrestin recruitment. This effect seemingly applies more to insulin release than to appetite regulation and nausea, possible reasons for which are discussed. At present, most evidence derives from cellular and animal studies, and more human data are required to determine whether this approach represents a genuine therapeutic advance. LINKED ARTICLES: This article is part of a themed issue on GLP1 receptor ligands (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.4/issuetoc

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.15497

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 45 references

Research works printed but not linked: 105

  1. 10.1111/bph.14748 · DOI · Paper page
  2. 10.1111/bph.14751 · DOI · Paper page
  3. 10.1016/S0140-6736(15)00803-X · DOI · Paper page
  4. 10.1038/s41467-020-14309-w · DOI · Paper page
  5. Avet C. Mancini A. Breton B. Le Gouill C. Hauser A. S. Normand C. Kobayashi H. Gross F. Hogue M. Lukasheva V. &Morissette S.(2020).Selectivity Landscape of 100 Therapeutically Relevant GPCR Profiled by an Effector Translocation‐Based BRET Platform. bioRxiv48: 2020.04.20.052027. · DOI
  6. 10.1172/JCI126309 · DOI · Paper page
  7. 10.1002/path.5056 · DOI · Paper page
  8. 10.3390/biology9120473 · DOI
  9. 10.1126/scitranslmed.aan0972 · DOI · Paper page
  10. 10.2337/diabetes.52.4.974 · DOI · Paper page
  11. 10.1371/journal.pbio.3000097 · DOI · Paper page
  12. 10.1371/journal.pbio.1000172 · DOI · Paper page
  13. 10.1038/nm.3997 · DOI · Paper page
  14. 10.1002/cbic.201900300 · DOI
  15. 10.1038/s41596-018-0028-3 · DOI · Paper page
  16. 10.1124/jpet.110.166009 · DOI
  17. 10.1016/j.molmet.2015.07.008 · DOI · Paper page
  18. 10.1083/jcb.131.1.69 · DOI · Paper page
  19. 10.1016/j.bcp.2020.114150 · DOI · Paper page
  20. 10.4161/cl.23967 · DOI · Paper page
  21. 10.3390/ijms21218404 · DOI · Paper page
  22. 10.1016/0026-0495(94)90132-5 · DOI
  23. 10.1016/j.bcp.2018.09.003 · DOI
  24. 10.1039/C9SC02079A · DOI
  25. Fridolf T., 1991, GLP‐1(7‐36) amide stimulates insulin secretion in rat islets: Studies on the mode of action, Diabetes Research, 16, 185
  26. 10.3389/fphys.2020.00555 · DOI · Paper page
  27. 10.1016/j.bcp.2016.03.003 · DOI
  28. 10.1126/scisignal.aaz3140 · DOI · Paper page
  29. 10.1016/j.tips.2020.09.009 · DOI · Paper page
  30. 10.1016/j.molmet.2017.08.002 · DOI · Paper page
  31. 10.1152/ajpgi.1989.257.3.G397 · DOI · Paper page
  32. Griffith D. A. Edmonds D. J. Fortin J. P. Kalgutkar A. S. Kuzmiski J. B. Loria P. M. Saxena A. R. Bagley S. W. Buckeridge C. Curto J. M. &Derksen D. R.(2020).A small‐molecule oral agonist of the human glucagon‐like peptide‐1 receptor. bioRxiv261: 2020.09.29.319483. · DOI
  33. 10.1038/s41467-017-02661-3 · DOI · Paper page
  34. 10.1016/j.bcp.2017.03.018 · DOI · Paper page
  35. 10.1021/jacs.6b08323 · DOI
  36. 10.1016/j.cmet.2011.02.001 · DOI · Paper page
  37. 10.1124/jpet.109.158519 · DOI
  38. 10.1016/j.peptides.2017.12.013 · DOI
  39. 10.1038/s41467-018-03941-2 · DOI · Paper page
  40. 10.1074/jbc.ra120.016334 · DOI · Paper page
  41. 10.1124/jpet.107.120006 · DOI
  42. 10.1113/jphysiol.2007.143818 · DOI · Paper page
  43. 10.1074/jbc.M108378200 · DOI · Paper page
  44. 10.1055/s-0030-1249035 · DOI
  45. 10.1038/srep41085 · DOI · Paper page
  46. 10.1124/mol.117.111187 · DOI
  47. 10.1021/cn200111m · DOI · Paper page
  48. 10.1111/j.1476-5381.1984.tb10753.x · DOI
  49. 10.1038/ncomms10842 · DOI · Paper page
  50. 10.1111/bph.15004 · DOI · Paper page
  51. 10.1124/mol.110.065664 · DOI · Paper page
  52. 10.1152/ajpendo.00551.2012 · DOI · Paper page
  53. 10.1073/pnas.94.26.14942 · DOI · Paper page
  54. 10.1021/jacs.9b05365 · DOI
  55. 10.1038/nature25773 · DOI · Paper page
  56. 10.1016/j.neuron.2017.09.042 · DOI · Paper page
  57. 10.1038/382083a0 · DOI · Paper page
  58. 10.1016/j.molmet.2020.100991 · DOI · Paper page
  59. 10.1073/pnas.041604898 · DOI · Paper page
  60. 10.1126/scisignal.aat7650 · DOI · Paper page
  61. 10.1016/j.coemr.2020.07.003 · DOI
  62. 10.1210/endo.140.3.6550 · doi:10.1210/endo.140.3.6550 · Paper page
  63. 10.1016/j.molmet.2021.101181 · DOI · Paper page
  64. 10.1172/JCI140046 · DOI · Paper page
  65. 10.1021/acssensors.9b01414 · DOI
  66. 10.1038/srep44247 · DOI
  67. 10.1016/S0140-6736(18)31773-2 · DOI · Paper page
  68. 10.1016/j.ejphar.2020.173706 · DOI
  69. 10.1111/bph.15134 · DOI · Paper page
  70. 10.1016/j.ejmech.2016.10.044 · DOI
  71. 10.1021/acscentsci.7b00237 · DOI
  72. 10.1074/jbc.M109.067207 · DOI · Paper page
  73. 10.1124/jpet.105.087254 · DOI · Paper page
  74. 10.1007/s00125-013-3130-7 · DOI
  75. 10.2337/dc20-0190 · DOI · Paper page
  76. 10.1074/jbc.M114.592436 · DOI · Paper page
  77. 10.1186/s12575-019-0116-y · DOI
  78. 10.1210/endo-121-3-1076 · DOI · Paper page
  79. 10.1111/jdi.12900 · DOI
  80. 10.1172/JCI72434 · DOI · Paper page
  81. 10.2337/diabetes.49.7.1156 · DOI · Paper page
  82. 10.2337/db12-1394 · DOI · Paper page
  83. 10.1016/j.bcp.2014.10.015 · DOI
  84. 10.1111/dom.13494 · DOI · Paper page
  85. 10.1042/bj20021288 · DOI · Paper page
  86. 10.1021/acsptsci.0c00193 · DOI
  87. 10.1074/jbc.RA118.001975 · DOI · Paper page
  88. 10.1016/j.neuroscience.2012.09.025 · DOI
  89. 10.1111/bph.12716 · DOI · Paper page
  90. 10.1038/s41598-017-03486-2 · DOI
  91. 10.1042/bj3100203 · DOI · Paper page
  92. 10.1038/s41580-018-0049-3 · DOI · Paper page
  93. 10.1016/j.cell.2016.05.023 · DOI · Paper page
  94. 10.1124/jpet.110.176362 · DOI
  95. 10.1073/pnas.0704796104 · DOI · Paper page
  96. 10.1016/j.bcp.2020.114001 · DOI · Paper page
  97. 10.1016/j.cmet.2006.10.001 · DOI · Paper page
  98. 10.1016/0167-0115(93)90137-W · DOI
  99. 10.1038/ncomms9918 · DOI · Paper page
  100. 10.1016/j.ydbio.2009.12.042 · DOI
  101. 10.1016/j.molcel.2020.09.020 · DOI · Paper page
  102. 10.1038/s41586-019-1902-z · DOI · Paper page
  103. 10.1001/jama.2018.3024 · DOI · Paper page
  104. 10.1038/srep26859 · DOI · Paper page
  105. 10.1038/ncomms14295 · DOI · Paper page

Cited by

See all 98

Metadata

Authors
Jones, B.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2021-05-20
Volume
179
Issue
4
Pages
492-510
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W3156815314
Cited by
98
References
45
FWCI
6.70
Type
journal article
Language
en
Open access
hybrid
Funders
  • Biotechnology and Biological Sciences Research Council
  • European Foundation for the Study of Diabetes
  • National Institute for Health Research
  • Sunesis
  • British Society for Neuroendocrinology
  • Society for Endocrinology
  • Engineering and Physical Sciences Research Council
  • NIHR Imperial Biomedical Research Centre
  • Academy of Medical Sciences
  • Medical Research Council Canada (MR/R010676/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The therapeutic potential of GLP‐1 receptor biased agonism. https://app.cochat.ai/papers/10.1111/bph.15497
The paper
Jones, B. (2022). The therapeutic potential of GLP‐1 receptor biased agonism. British Journal of Pharmacology. https://doi.org/10.1111/bph.15497

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.